Otilimab
Product Specifications
CAS Number
1638332-55-4
Target
C-Fms|||CSF-1R
Related Pathways
Tyrosine Kinase/Adaptors
Purity
>95%
Bioactivity
Otilimab (GSK 3196165) is a humanized monoclonal antibody against granulocyt-macrophage colony-stimulating factor (GM-CSF) . Otilimab has anti-inflammatory activity, regulates the biological function of GM-CSF by blocking the interaction between GM-CSF and its cell surface receptors, and can be used in studies to treat severe COVID-19 pneumonia.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2057647-01 0.1 mL
APC/CY7-Linked Polyclonal Antibody to Carnitine Acylcarnitine Translocase (CACT)
Ask
View Details MBS2057647-02 0.2 mL
APC/CY7-Linked Polyclonal Antibody to Carnitine Acylcarnitine Translocase (CACT)
Ask
View Details MBS2057647-03 0.5 mL
APC/CY7-Linked Polyclonal Antibody to Carnitine Acylcarnitine Translocase (CACT)
Ask
View Details MBS2057647-04 1 mL
APC/CY7-Linked Polyclonal Antibody to Carnitine Acylcarnitine Translocase (CACT)
Ask
View Details